As of 2024-12-14, the Relative Valuation of Vifor Pharma AG (VIFN.SW) is 84.93 CHF. This relative valuation is based on P/E multiples. With the latest stock price at 166.15 CHF, the upside of Vifor Pharma AG based on Relative Valuation is -48.9%.
The range of the Relative Valuation is 42.95 - 131.06 CHF.
| Range | Selected | |
| Trailing P/E multiples | 19.3x - 23.7x | 21.0x |
| Forward P/E multiples | 22.6x - 26.2x | 24.6x |
| Fair Price | 42.95 - 131.06 | 84.93 |
| Upside | -74.2% - -21.1% | -48.9% |
| Date | P/E |